| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 745287 | Null | 0.0446159312763229 | -0.15888915 |
| NSC 748498 | Null | 0.0446159312763229 | 0.27951065 |
| NSC 756169 | GSK317314A | 0.0446159312763229 | 0.18322956 |
| NSC 317908 | Null | 0.0446159312763235 | 0.040015208 |
| NSC 722316 | Null | 0.0446159312763235 | 0.037663085 |
| NSC 734977 | Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate | 0.0446159312763235 | 0.12604524 |
| NSC 740385 | 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide | 0.0446159312763235 | 0.26896336 |
| NSC 174218 | Phenol, 2,2'-[1,2-ethanediylbis(nitrilomethylidyne)]bis-, compd. with dichlorodipropylstannane (1:1) | 0.0459335986102865 | 0.40154124 |
| NSC 200692 | Aspiculamycin hydrochloride | 0.0459335986102865 | 0.065821926 |
| NSC 240529 | 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- | 0.0459335986102865 | 0.12618011 |